Mei Xie
-
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 6
- Ferroptosis and cancer prognosis 2
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
-
- RNA modifications and cancer 2
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Mei Xie
26 papers receiving 249 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 65
- Oncology 100
- Pulmonary and Respiratory Medicine 99
- Immunology 41
- Molecular Biology 93
Countries citing papers authored by Mei Xie
This map shows the geographic impact of Mei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Xie more than expected).
Fields of papers citing papers by Mei Xie
This network shows the impact of papers produced by Mei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Xie. The network helps show where Mei Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mei Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 15 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 14 | |
| 16 | 2022 | 16 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 21 | |
| 19 | 2017 | 23 | |
| 20 | 2010 | 5 |
About Mei Xie
Mei Xie is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 28 papers that have together received 251 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (2 papers), Lung Cancer Research Studies (2 papers), Ferroptosis and cancer prognosis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (65 citations), Oncology (100 citations) and Pulmonary and Respiratory Medicine (99 citations). Mei Xie has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yuanyong Wang, Xidong Ma, Xinying Xue, Jialin Song, Zhaoyang Wang, Xiaolong Yan, Fen Zhao, Guofang Lu, Xiaoling Zou and Changjian Shao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.